Journal of Anesthesia

, Volume 20, Issue 3, pp 179–182 | Cite as

Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery

  • Tomoki Nishiyama
  • Takeshi Yokoyama
  • Koichi Yamashita



Ulinastatin is well known to inhibit the activity of polymorphonuclear leukocyte elastase (PMNE). The PMNE concentration correlates with the activities of coagulation and fibrinolysis. The purpose of the present study was to investigate the effects of ulinastatin, a protease inhibitor, on coagulation and fibrinolysis in abdominal surgery.


Thirty patients, aged 40 to 70 years, with American Society of Anesthesiologists (ASA) physical status I or II, scheduled for major abdominal surgery, were enrolled. Anesthesia was induced with midazolam and thiopental, and was maintained with sevoflurane, nitrous oxide in oxygen, and an epidural block. An infusion of ulinastatin, 6000 units·kg−1 in 30 min, was started 1 h after the start of surgery in the ulinastatin group (15 patients). In the control group (15 patients), no protease inhibitors were infused. White blood cell count; platelet count; prothrombin time; activated partial thromboplastin time; and plasma concentrations of PMNE, antithrombin (AT), fibrin/fibrinogen degradation product (FDP), fibrinogen, plasminogen, plasmin-α2 plasmin inhibitor complex (PIC), and thrombin-antithrombin complex (TAT) were measured before, at the end of, and 12 h after surgery.


TAT, PIC, and FDP after surgery were significantly lower in the ulinastatin group than in the control group. AT was decreased in the control group but not in the ulinastatin group, with significant differences between the two groups.


Ulinastatin could inhibit coagulation and fibrinolysis in abdominal surgery.

Key words

Polymorphonuclear leukocyte elastase Protease inhibitor Ulinastatin Coagulation Fibrinolysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nishiyama, T, Hirasaki, A 1994Effect of ulinastatin on the elastase release in multiple injuriesAnesth Res307780Google Scholar
  2. 2.
    Nishiyama, T, Hanaoka, K 2001Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6?Crit Care Med2921062110PubMedCrossRefGoogle Scholar
  3. 3.
    Aosasa, S, Ono, S, Mochizuki, H, Tsujimoto, H, Ueno, C, Matsumoto, A 2001Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor α production of monocytesShock15101105PubMedCrossRefGoogle Scholar
  4. 4.
    Sato, Y, Ishikawa, S, Otaki, A, Takahashi, T, Hasegawa, Y, Suzuki, M, Yamagishi, T, Mirishita, Y 2000Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injuryJpn J Thorac Cardiovasc Surg48428434PubMedGoogle Scholar
  5. 5.
    Yamaguchi, Y, Ohshiro, H, Nagao, Y, Odawara, K, Okabe, K, Hidaka, H, Ishihara, K, Uchino, S, Furuhashi, T, Yamada, S, Mori, K, Ogawa, M 2000Urinary trypsin inhibitor reduces C⎓X⎓C chemokine production in rat liver ischemia/reperfusionJ Surg Res94107115PubMedCrossRefGoogle Scholar
  6. 6.
    Cao, ZL, Okazaki, Y, Naito, K, Ueno, T, Natsuaki, M, Itoh, T 2000Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heartAnn Thorac Surg6911211126PubMedCrossRefGoogle Scholar
  7. 7.
    Nishiyama, T, Yokoyama, T, Hanaoka, K 1996Correlations between plasma levels of polymorphonuclear leukocyte elastase and coagulation and fibrinolysis parameters in patients undergoing major abdominal surgeryAnesth Res32369372Google Scholar
  8. 8.
    Kopec, M, Bykowska, K, Lopaciuk, S, Jelenska, M, Kaczanowska, J, Sopata, I, Wojtecka, E 1980Effects of neutral proteases from human leukocytes on structure and biological properties of human factor VIIIThromb Haemost43211217PubMedGoogle Scholar
  9. 9.
    Kawamura, T, Inada, K, Kimura, O, Akasaka, N, Wakusawa, R 1994The inhibitory effects of ulinastatin on the increase of interleukin 8 and 6 during open heart surgeryMasui (Jpn J Anesthesiol)4318181823Google Scholar
  10. 10.
    Pelzer, H, Schwarz, A, Heimburger, N 1988Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assayThromb Haemost59101106PubMedGoogle Scholar
  11. 11.
    Yoshikawa, T, Murakami, M, Seto, O, Sugino, S, Kondo, M 1987Prevention of endotoxin-induced disseminated intravascular coagulation, and inhibition of endotoxin-induced release of thromboplastin activity from leukocytes by a protease-inhibitor, ulinastatin (in Japanese with English abstract)Masui (Jpn J Anesthesiol)3612811285Google Scholar
  12. 12.
    Nishiyama, T, Sato, K, Konishi, H, Seto, K 1991Changes in polymorphonuclear leukocyte elastase activity and other parameters in response to surgical invasion (in Japanese with English abstract)ICU to CCU (Jpn J Int Care Med)1510551061Google Scholar
  13. 13.
    Perlmutter, DH, Pierce, JA 1989The α1-antitrypsin gene and emphysemaAm J Physiol257L147162PubMedGoogle Scholar
  14. 14.
    Banda, MJ, Rice, AG, Griffin, GL, Senior, RM 1988The inhibitory complex of human α1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractantJ Exp Med16716081615PubMedCrossRefGoogle Scholar
  15. 15.
    Plow, EF 1986The contribution of leukocyte proteases to fibrinolysisBlut5319PubMedCrossRefGoogle Scholar
  16. 16.
    Brower, MS, Walz, DA, Garry, KE, Fenton, JW,2nd 1987Human neutrophil elastase alters human α-thrombin function: limited proteolysis near the γ-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activityBlood69813819PubMedGoogle Scholar
  17. 17.
    Taki, M, Miura, T, Inagaki, M, Tomita, Y, Saito, N, Okada, Y, Tsuda, Y, Meguro, T, Yamada, K 1986Influence of granulocyte elastase-like proteinase (ELP) on platelet functionsThromb Res41837846PubMedCrossRefGoogle Scholar
  18. 18.
    Jochum, M, Lander, S, Heimburger, N, Fritz, H 1981Effect of human granulocytic elastase on isolated human antithrombin IIIHoppe-Seyler's Z Physiol Chem362103112PubMedGoogle Scholar
  19. 19.
    Bjørk, P, Axelsson, L, Bergenfeldt, M, Ohlsson, K 1988Influence of plasma protease inhibitors and the secretory leukocyte protease inhibitor on leukocyte elastase-induced consumption of selected plasma proteins in vitro in manScand J Clin Lab Invest48205211PubMedGoogle Scholar
  20. 20.
    Henriksson, P, Nilsson, IM, Ohlsson, K, Stenberg, P 1980Granulocyte elastase activation and degradation of factor XIIIThromb Res18343351PubMedCrossRefGoogle Scholar
  21. 21.
    Nishiyama, T, Aibiki, M, Hanaoka, K 1996The effect of ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastaseAnesth Analg82108112PubMedCrossRefGoogle Scholar
  22. 22.
    Gando, S, Kameue, T, Namzaki, S, Nakanishi, Y 1995Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndromeThromb Res80519526PubMedCrossRefGoogle Scholar
  23. 23.
    Massignon, D, Lepape, A, Bienvenu, J, Barbier, Y, Boileau, C, Coeur, P 1994Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical stateHaemostasis243648PubMedGoogle Scholar

Copyright information

© JSA 2006

Authors and Affiliations

  • Tomoki Nishiyama
    • 1
  • Takeshi Yokoyama
    • 2
  • Koichi Yamashita
    • 2
  1. 1.Department of AnesthesiologyThe University of TokyoTokyoJapan
  2. 2.Department of Anesthesiology and Critical Care MedicineKochi University Medical SchoolKochiJapan

Personalised recommendations